Announce Date | 05/06/2025 |
EPS Normalized Actual | $0.4 (Beat by $0.01) |
EPS GAAP Actual | $0.4 (Beat by $0.01) |
Revenue Actual | $0.244979B |
Revenue Surprise | Beat by $244.979M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.02 |
EPS GAAP Estimate | $-0.02 |
Revenue Estimate | $0.246877B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 8.76 | 1.66 | 8.58016 | 8.96148 | 1 |
Dec 2026 | -0.595 | -24.39 | -1.25 | 0.06 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | -0.0053 | -0.0053 | 0.244979B | -5.84% | 244.98M |
FQ3 2024 (Sep 2024) | 0.0276 | 0.0276 | 0.109092B | -134.12% | 109.09M |
FQ2 2024 (Jun 2024) | 0.063 | 0.063 | 0.245777B | -3.1% | 245.78M |
FQ1 2024 (Mar 2024) | 0.0512 | 0.0512 | 0.244969B | -3.03% | 244.97M |
FQ4 2023 (Dec 2023) | -0.24 | -0.24 | 0.259279B | 1.98% | 259.28M |
FQ3 2023 (Sep 2023) | -0.0801 | -0.0801 | 0.255409B | 0.68% | 255.41M |
FQ2 2023 (Jun 2023) | -0.0429 | -0.0429 | 0.253407B | 2.54% | 253.41M |
FQ1 2023 (Mar 2023) | -0.38 | -0.38 | 0.252393B | 100% | 252.39M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
-0.02
Consensus Revenue Estimates
0.246877B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0 | -- | 0 | 0 | 0 |
FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 0 |
FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 0 |
FQ4 2026 (Oct 2026) | 0.02 | -- | 0.0196661 | 0.0202745 | 1 |
FQ3 2026 (Jul 2026) | 0.01 | -- | 0.00983305 | 0.01013725 | 1 |
FQ2 2026 (Jun 2026) | 0.01 | -- | 0.00981723 | 0.0101757 | 1 |
FQ1 2026 (Mar 2026) | -0.06 | -- | -0.06140893 | -0.0577896 | 2 |
FQ4 2025 (Oct 2025) | -0.02 | 73.5 | -0.0202745 | -0.0196661 | 2 |
FQ3 2025 (Jul 2025) | -0.02 | 238 | -0.0202745 | -0.0196661 | 2 |
FQ2 2025 (Jun 2025) | -0.02 | 415 | -0.02035139 | -0.01963445 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.26B | -- | 0.26B | 0.26B | 1 |
FQ2 2027 (Jun 2027) | 0.26B | -- | 0.26B | 0.26B | 1 |
FQ1 2027 (Mar 2027) | 0.26B | -- | 0.25B | 0.26B | 1 |
FQ4 2026 (Oct 2026) | 0.28B | -- | 0.28B | 0.29B | 2 |
FQ3 2026 (Jul 2026) | 0.28B | -- | 0.28B | 0.28B | 2 |
FQ2 2026 (Jun 2026) | 0.91B | -- | 0.89B | 0.92B | 2 |
FQ1 2026 (Mar 2026) | 0.25B | -- | 0.24B | 0.25B | 4 |
FQ4 2025 (Oct 2025) | 0.25B | 1.22 | 0.24B | 0.25B | 1 |
FQ3 2025 (Jul 2025) | 0.25B | 55.7 | 0.24B | 0.25B | 1 |
FQ2 2025 (Jun 2025) | 0.25B | 0.45 | 0.24B | 0.25B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | -0.0053 | -0.0053 | 100% | |
FQ3 2024 (Sep 2024) | 0.0276 | 0.0276 | 100% | |
FQ2 2024 (Jun 2024) | 0.063 | 0.063 | 100% | |
FQ1 2024 (Mar 2024) | 0.0512 | 0.0512 | 100% | |
FQ4 2023 (Dec 2023) | -0.24 | -0.24 | 100% | |
FQ3 2023 (Sep 2023) | -0.0801 | -0.0801 | 100% | |
FQ2 2023 (Jun 2023) | -0.0429 | -0.0429 | 100% | |
FQ1 2023 (Mar 2023) | -0.38 | -0.38 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $0.24B | $244.98M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.11B | $109.09M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.25B | $245.78M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.24B | $244.97M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.26B | $259.28M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.26B | $255.41M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.25B | $253.41M | 100% |
FQ1 2023 (Mar 2023) | $0B | $0.25B | $252.39M | 100% |